• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Month: October 2020

Finance

4D pharma plc announces merger with Longevity, a special purpose acquisition company (SPAC), and its intention to gain a NASDAQ listing

October 28, 2020 Staff Editor

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) – a novel class of drug derived from the microbiome – and Longevity Acquisition Corporation (NASDAQ: LOAC) (“Longevity”), a […]

Reports

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

October 26, 2020 Luis Gosálbez

This content is restricted.

Premium Content

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

October 26, 2020 Luis Gosálbez

There is no excerpt because this is a protected post.

Market Reports

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

October 26, 2020 Luis Gosálbez

Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new […]

Pharma & Human Health

Ingestible capsule that could help demystify the gut-brain axis

October 26, 2020 Staff Editor

Anyone who has experienced “butterflies in the stomach” before giving a big presentation will be unsurprised to learn there is a physical connection between their gut and their brain. Neuroscientists and medical professionals call this […]

No Picture
Video

Virus Discovery and Surveillance Using Viral Metagenomics

October 23, 2020 Tasha M. Santiago-Rodriguez

Viruses are ubiquitous structures that can infect cells from various forms of life. Determining viral community structure and function in association with health and disease is of increasing interest. This field, also known as viral […]

Finance

Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners

October 23, 2020 Staff Editor

Solarea Bio, a biotech company based in Cambridge, MA developing microbial-based solutions to aid human health, announced today it has raised $11.2M in a Series A financing led by S2G Ventures and Bold Capital Partners, […]

Finance

MyBiotics Awarded 2 Million Euro Grant from the European Union

October 22, 2020 Staff Editor

MyBiotics Pharma Ltd., a microbiome therapeutics company, announced today that it was awarded 2.0 million Euros ($2.3 million) by the European Union as part of its Horizon 2020 Program. The grant will support the development of a […]

Pharma & Human Health

A tale of two cesspits: DNA reveals intestinal health in Medieval Europe and Middle East

October 19, 2020 Staff Editor

A new study published this week in the journal Philosophical Transactions of the Royal Society B demonstrates a first attempt at using the methods of ancient bacterial detection, pioneered in studies of past epidemics, to […]

Finance

Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program

October 14, 2020 Staff Editor

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the advancement to large-scale production of BMC128, its Live Bacterial Product (LBP) candidate consortium. […]

Finance

Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies

October 12, 2020 Staff Editor

Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million Series A financing and expanded its leadership team. […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    January 20, 2021
  • Poor gut health connected to severe COVID-19, new review shows
    January 18, 2021
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter